Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adherence with Travalert for fixed-dose travoprost/timolol versus concomitant travoprost plus timolol
2007-000515-29Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Jul 2007
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of travoprost and timolol in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Alcon Inc. Primary endpoint: Primary adherence endpoint. Started Jul 2007; status: completed.
02
Drugs
travoprosttimolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2007-000515-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000515-29.